Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders

 
 

Adial Pharmaceuticals, L.L.C. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-18Dec-31-17Dec-31-16Dec-31-15
Revenues0.00.00.00.0
            Revenue growth31.8%   
Cost of goods sold0.00.00.00.0
Gross profit0.00.00.00.0
            Gross margin0.0%0.0%  
Research and development0.40.2146,143.0322,107.0
General and administrative6.60.8264,664.0497,150.0
EBITA-7.0-1.0-410,807.0-818,692.0
            EBITA margin-150672.0%-28275.2%  
Amortization of intangibles0.00.0 565.0
EBIT-7.0-1.0-410,807.0-819,257.0
            EBIT margin-150684.1%-28291.2%  
Pre-tax income-11.6-1.1-420,200.0-817,993.0
Income taxes0.00.00.00.0
            Tax rate0.0%0.0%0.0%0.0%
Net income-11.6-1.1-420,200.0-817,993.0
            Net margin-250838.4%-32389.3%  
 
Diluted EPS($2.44)($0.35)($128,974.75) 
Shares outstanding (diluted)4.83.33.3 
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2018 | Contact Us | Data Disclaimer | Terms of Use | Privacy